PI
Amsterdam Neuroscience
-
Clinical and humoral responses after SARS-CoV-2 breakthrough infections in patients with immunosuppressants
T2B! immunity against SARS-CoV-2 study group, 17 May 2024, (E-pub ahead of print) In: Journal of allergy and clinical immunology.Research output: Contribution to journal › Article › Academic › peer-review
-
Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: Evidence from real-world clinical data
Noteboom, S., Strijbis, E. M. M., Coerver, E. M. E., Colato, E., van Kempen, Z. L. E., Jasperse, B., Vrenken, H., Killestein, J., Schoonheim, M. M. & Steenwijk, M. D., Jul 2024, In: Multiple Sclerosis and Related Disorders. 87, p. 105670 105670.Research output: Contribution to journal › Article › Academic › peer-review
-
Surrogate endpoints for progressive multifocal leukoencephalopathy
Killestein, J. & Wattjes, M. P., 1 May 2024, In: The Lancet Neurology. 23, 5, p. 455-456 2 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications